Skip to main content
Erschienen in: Journal of Neurology 6/2017

17.05.2017 | Original Communication

Long-term outcomes of epilepsy surgery in tuberous sclerosis complex

verfasst von: Shuli Liang, Juncheng Zhang, Zhixian Yang, Shaohui Zhang, Zhiqiang Cui, Jianfei Cui, Jiwu Zhang, Na Liu, Ping Ding

Erschienen in: Journal of Neurology | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Approximately 50% of patients with tuberous sclerosis complex (TSC) present intractable epilepsy, and surgery is an option for those patients. Hereby, we analyze long-term seizure control and neuropsychological outcomes of epilepsy surgery in patients with TSC. Clinical data were retrospectively collected from 66 patients with TSC and epilepsy followed up over 5 years, 51 of whom underwent epilepsy surgery between 2001 and 2011. Reductions in the number of seizures were analyzed at 1-year (1FU), 5-year (5FU), and 10-year (10FU) follow-ups visits after the operation. Influential factors on postoperative seizure free and intelligence quotient (IQ) and quality-of-life (QOL) outcomes were evaluated at 5FU. Resective procedures included 26 tuber resections, 15 lobectomies, and 10 tuber resections and lobectomies. Corpus callosotomies were performed as the adjunctive approach in 11 cases with low IQ. The percentages of seizure-free cases were 74.5% at 1FU, 58.8% at 5FU, and 47.8% at 10FU, and the predictive factor for long-term postoperative seizure freedom was the history of preoperative seizures and preoperative full-scale IQ. Significant improvements were found in performance IQ, full-scale IQ, and QOL in patients from the surgery group, particularly those who were seizure free after the operation. Our study showed that epilepsy surgery in TSC with epilepsy rendered improvements in seizure control, full-scale IQ, and QOL. Satisfactory long-term seizure control was often achieved with an early operation and without mental retardation, and improvements in QOL and IQ were frequently observed in postoperative patients who remained seizure free.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Li H, Jin F, Jiang K et al (2016) mTORC1-mediated down regulation of COX2 restrains tumor growth caused by TSC2 deficiency. Oncotarget 7:28435–28447CrossRefPubMedPubMedCentral Li H, Jin F, Jiang K et al (2016) mTORC1-mediated down regulation of COX2 restrains tumor growth caused by TSC2 deficiency. Oncotarget 7:28435–28447CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Kingswood JC, Bruzzi P, Curatolo P et al (2014) TOSCA—first international registry to address knowledge gaps in the natural history and management of tuberous sclerosis complex. Orphanet J Rare Dis 9:182CrossRefPubMedPubMedCentral Kingswood JC, Bruzzi P, Curatolo P et al (2014) TOSCA—first international registry to address knowledge gaps in the natural history and management of tuberous sclerosis complex. Orphanet J Rare Dis 9:182CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Hunold A, Haueisen J, Ahtam B et al (2014) Localization of the epileptogenic foci in tuberous sclerosis complex: a pediatric case report. Front Hum Neurosci 8:175CrossRefPubMedPubMedCentral Hunold A, Haueisen J, Ahtam B et al (2014) Localization of the epileptogenic foci in tuberous sclerosis complex: a pediatric case report. Front Hum Neurosci 8:175CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Crino PB, Nathanson KL, Henske EP (2006) The tuberous sclerosis complex. N Engl J Med 355:1345–1356CrossRefPubMed Crino PB, Nathanson KL, Henske EP (2006) The tuberous sclerosis complex. N Engl J Med 355:1345–1356CrossRefPubMed
6.
7.
Zurück zum Zitat Overwater IE, Bindels-de Heus K, Rietman AB et al (2015) Epilepsy in children with tuberous sclerosis complex: chance of remission and response to antiepileptic drugs. Epilepsia 56:1239–1245CrossRefPubMed Overwater IE, Bindels-de Heus K, Rietman AB et al (2015) Epilepsy in children with tuberous sclerosis complex: chance of remission and response to antiepileptic drugs. Epilepsia 56:1239–1245CrossRefPubMed
8.
Zurück zum Zitat Krueger D, Wilfong A, Holland-Bouley K et al (2013) Everolimus treatment of refractory epilepsy in tuberous sclerosis complex. Ann Neurol 74:679–687CrossRefPubMed Krueger D, Wilfong A, Holland-Bouley K et al (2013) Everolimus treatment of refractory epilepsy in tuberous sclerosis complex. Ann Neurol 74:679–687CrossRefPubMed
9.
Zurück zum Zitat Jansen FE, van Huffelen AC, Algra A et al (2007) Epilepsy surgery in tuberous sclerosis: a systematic review. Epilepsia 48:1477–1484CrossRefPubMed Jansen FE, van Huffelen AC, Algra A et al (2007) Epilepsy surgery in tuberous sclerosis: a systematic review. Epilepsia 48:1477–1484CrossRefPubMed
10.
Zurück zum Zitat Zhang K, Hu WH, Zhang C et al (2013) Predictors of seizure freedom after surgical management of tuberous sclerosis complex: a systematic review and meta analysis. Epilepsy Res 105:377–383CrossRefPubMed Zhang K, Hu WH, Zhang C et al (2013) Predictors of seizure freedom after surgical management of tuberous sclerosis complex: a systematic review and meta analysis. Epilepsy Res 105:377–383CrossRefPubMed
11.
Zurück zum Zitat Fallah A, Guyatt GH, Snead OC III et al (2014) Predictors of seizure outcomes in children with tuberous sclerosis complex and intractable epilepsy undergoing resective epilepsy surgery: an individual participant data meta-analysis. PLoS One 8:e53565CrossRef Fallah A, Guyatt GH, Snead OC III et al (2014) Predictors of seizure outcomes in children with tuberous sclerosis complex and intractable epilepsy undergoing resective epilepsy surgery: an individual participant data meta-analysis. PLoS One 8:e53565CrossRef
12.
Zurück zum Zitat Liang S, Li A, Zhao M et al (2010) Epilepsy surgery in tuberous sclerosis complex: emphasis on surgical candidate and neuropsychology. Epilepsia 51:2316–2321CrossRefPubMed Liang S, Li A, Zhao M et al (2010) Epilepsy surgery in tuberous sclerosis complex: emphasis on surgical candidate and neuropsychology. Epilepsia 51:2316–2321CrossRefPubMed
13.
Zurück zum Zitat Shahid A (2013) Resecting the epileptogenic tuber: what happens in the long term? Epilepsia 54:135–138CrossRefPubMed Shahid A (2013) Resecting the epileptogenic tuber: what happens in the long term? Epilepsia 54:135–138CrossRefPubMed
14.
Zurück zum Zitat Roach ES, Sparagana SP (2004) Diagnosis of tuberous sclerosis complex. J Child Neurol 19:643–649CrossRefPubMed Roach ES, Sparagana SP (2004) Diagnosis of tuberous sclerosis complex. J Child Neurol 19:643–649CrossRefPubMed
15.
Zurück zum Zitat Koh S, Jayakar P, Dunoyer C et al (2000) Epilepsy surgery in children with tuberous sclerosis complex: presurgical evaluation and outcome. Epilepsia 41:1206–1213CrossRefPubMed Koh S, Jayakar P, Dunoyer C et al (2000) Epilepsy surgery in children with tuberous sclerosis complex: presurgical evaluation and outcome. Epilepsia 41:1206–1213CrossRefPubMed
16.
Zurück zum Zitat Jansen FE, van Huffelen AC, Bourez-Swart M et al (2005) Consistent localization of interictal epileptiform activity on EEGs of patients with tuberous sclerosis complex. Epilepsia 46:415–419CrossRefPubMed Jansen FE, van Huffelen AC, Bourez-Swart M et al (2005) Consistent localization of interictal epileptiform activity on EEGs of patients with tuberous sclerosis complex. Epilepsia 46:415–419CrossRefPubMed
17.
Zurück zum Zitat Liang S, Wang S, Zhang J et al (2012) Long-term outcomes of epilepsy surgery in school-aged children with partial epilepsy. Pediatr Neurol 47:284–290CrossRefPubMed Liang S, Wang S, Zhang J et al (2012) Long-term outcomes of epilepsy surgery in school-aged children with partial epilepsy. Pediatr Neurol 47:284–290CrossRefPubMed
18.
Zurück zum Zitat Bollo RJ, Kalhorn SP, Carlson C et al (2008) Epilepsy surgery and tuberous sclerosis complex: special considerations. Neurosurg Focus 25:13CrossRef Bollo RJ, Kalhorn SP, Carlson C et al (2008) Epilepsy surgery and tuberous sclerosis complex: special considerations. Neurosurg Focus 25:13CrossRef
19.
Zurück zum Zitat Weiner HL, Carlson C, Ridgway EB et al (2006) Epilepsy surgery in young children with tuberous sclerosis: results of a novel approach. Pediatrics 117:1494–1502CrossRefPubMed Weiner HL, Carlson C, Ridgway EB et al (2006) Epilepsy surgery in young children with tuberous sclerosis: results of a novel approach. Pediatrics 117:1494–1502CrossRefPubMed
20.
Zurück zum Zitat Arya R, Tenney JR, Horn PS et al (2015) Long-term outcomes of resective epilepsy surgery after invasive presurgical evaluation in children with tuberous sclerosis complex and bilateral multiple lesions. J Neurosurg Pediatr 15:26–33CrossRefPubMed Arya R, Tenney JR, Horn PS et al (2015) Long-term outcomes of resective epilepsy surgery after invasive presurgical evaluation in children with tuberous sclerosis complex and bilateral multiple lesions. J Neurosurg Pediatr 15:26–33CrossRefPubMed
21.
Zurück zum Zitat Krsek P, Jahodova A, Kyncl M, Kudr M, Komarek V, Jezdik P, Jayakar P, Miller I, Korman B, Rey G, Resnick T, Duchowny M (2013) Predictors of seizure-free outcome after epilepsy surgery for pediatric tuberous sclerosis complex. Epilepsia 54(11):1913–1921CrossRefPubMed Krsek P, Jahodova A, Kyncl M, Kudr M, Komarek V, Jezdik P, Jayakar P, Miller I, Korman B, Rey G, Resnick T, Duchowny M (2013) Predictors of seizure-free outcome after epilepsy surgery for pediatric tuberous sclerosis complex. Epilepsia 54(11):1913–1921CrossRefPubMed
22.
Zurück zum Zitat Song P, Joo EY, Seo DW et al (2012) Seizure localization in patients with multiple tubers: presurgical evaluation in tuberous sclerosis. J Epilepsy Res 2:16–20CrossRefPubMedPubMedCentral Song P, Joo EY, Seo DW et al (2012) Seizure localization in patients with multiple tubers: presurgical evaluation in tuberous sclerosis. J Epilepsy Res 2:16–20CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Wu JY, Salamon N, Kirsch HE et al (2010) Noninvasive testing, early surgery, and seizure freedom in tuberous sclerosis complex. Neurology 74:392–398CrossRefPubMedPubMedCentral Wu JY, Salamon N, Kirsch HE et al (2010) Noninvasive testing, early surgery, and seizure freedom in tuberous sclerosis complex. Neurology 74:392–398CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Yogi A, Hirata Y, Karavaeva E et al (2015) DTI of tuber and perituberal tissue can predict epileptogenicity in tuberous sclerosis complex. Neurology 85:2011–2015CrossRefPubMedPubMedCentral Yogi A, Hirata Y, Karavaeva E et al (2015) DTI of tuber and perituberal tissue can predict epileptogenicity in tuberous sclerosis complex. Neurology 85:2011–2015CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Abdijadid S, Mathern GW, Levine MS et al (2015) Basic mechanisms of epileptogenesis in pediatric cortical dysplasia CNS. Neurosci Ther 21:92–103CrossRef Abdijadid S, Mathern GW, Levine MS et al (2015) Basic mechanisms of epileptogenesis in pediatric cortical dysplasia CNS. Neurosci Ther 21:92–103CrossRef
26.
Zurück zum Zitat Cepeda C, Andre VM, Yamazaki I et al (2010) Comparative study of cellular and synaptic abnormalities in brain tissue samples from pediatric tuberous sclerosis complex and cortical dysplasia type II. Epilepsia 51:160–165CrossRefPubMedPubMedCentral Cepeda C, Andre VM, Yamazaki I et al (2010) Comparative study of cellular and synaptic abnormalities in brain tissue samples from pediatric tuberous sclerosis complex and cortical dysplasia type II. Epilepsia 51:160–165CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Mühlebner A, van Scheppingen J, Hulshof HM et al (2016) Novel histopathological patterns in cortical tubers of epilepsy surgery patients with tuberous sclerosis complex. PLoS One 11:e0157396CrossRefPubMedPubMedCentral Mühlebner A, van Scheppingen J, Hulshof HM et al (2016) Novel histopathological patterns in cortical tubers of epilepsy surgery patients with tuberous sclerosis complex. PLoS One 11:e0157396CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Ma TS, Elliott RE, Ruppe V et al (2012) Electrocorticographic evidence of perituberal cortex epileptogenicity in tuberous sclerosis complex clinical article. J Neurosurg Pediatrics 10:376–382CrossRef Ma TS, Elliott RE, Ruppe V et al (2012) Electrocorticographic evidence of perituberal cortex epileptogenicity in tuberous sclerosis complex clinical article. J Neurosurg Pediatrics 10:376–382CrossRef
29.
Zurück zum Zitat Ruppe V, Dilsiz P, Reiss CS et al (2014) Developmental brain abnormalities in tuberous sclerosis complex: a comparative tissue analysis of cortical tubers and perituberal cortex. Epilepsia 55:539–550CrossRefPubMed Ruppe V, Dilsiz P, Reiss CS et al (2014) Developmental brain abnormalities in tuberous sclerosis complex: a comparative tissue analysis of cortical tubers and perituberal cortex. Epilepsia 55:539–550CrossRefPubMed
30.
Zurück zum Zitat Oh S, Stewart T, Miller I et al (2011) In vivo optical properties of cortical tubers in children with tuberous sclerosis complex (TSC): a preliminary investigation. Epilepsia 52:1699–1704CrossRefPubMed Oh S, Stewart T, Miller I et al (2011) In vivo optical properties of cortical tubers in children with tuberous sclerosis complex (TSC): a preliminary investigation. Epilepsia 52:1699–1704CrossRefPubMed
Metadaten
Titel
Long-term outcomes of epilepsy surgery in tuberous sclerosis complex
verfasst von
Shuli Liang
Juncheng Zhang
Zhixian Yang
Shaohui Zhang
Zhiqiang Cui
Jianfei Cui
Jiwu Zhang
Na Liu
Ping Ding
Publikationsdatum
17.05.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 6/2017
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-017-8507-y

Weitere Artikel der Ausgabe 6/2017

Journal of Neurology 6/2017 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.